DelveInsight's "Anemia Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth understanding of ...

Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, U.K. Chemistry Research ...

ZYAN1 is an oral small molecule that has been designed to inhibit hypoxia-inducible factor prolyl hydroxylase, and thereby increase the natural production of hemoglobin and RBCs in anemic patients.

Target-range hemoglobin levels were maintained over 1 year in patients on dialysis switching from the long-acting ESA to thrice-weekly vadadustat. Vadadustat is noninferior to methoxy polyethylene ...

This included patients on dialysis, including both hemo- and peritoneal dialysis, and those not on dialysis, regardless of prior anaemia treatment with erythropoiesis-stimulating agents (ESAs ...

Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. *Corresponding Author: Frank S. Lee, Department of Pathology and ...